Forschungsnetzwerke – Rheumaforschungsgruppe Ruhr

  • J. Braun
  • X. Baraliakos
  • U. Kiltz
  • E. Schmitz-Bortz
  • L. Kalthoff
  • D. Krause
Rheumaforschungsgruppe Ruhr
  • 1 Downloads

Schlüsselwörter

Forschungsprojekte Rheumatologie Glukokortikoide Fachassistenten Klinische Studien 

Research networks—Rheumatism research group Ruhr

Keywords

Research project Rheumatology Glucocorticoid Specialist assistant Clinical Studies 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

J. Braun, X. Baraliakos, U. Kiltz, E. Schmitz-Bortz, L. Kalthoff und D. Krause geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Trampisch US, Krause D, Trampisch HJ, Klaassen-Mielke R, Baraliakos X, Braun J (2014) Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial. Trials 15:344CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial (EudraCT-Nr.: 2012-004074-25; Prüfplancode: 01KG1204)Google Scholar
  3. 3.
    Krause D, Rau R, Braun J (2011) Glucocorticoid treatment in early rheumatoid arthritis. Clin Exp Rheumatol 29(5 Suppl 68):S121–S125PubMedGoogle Scholar
  4. 4.
    Strukturierte Delegation ärztlicher Leistungen im Rahmen konzeptionsgeregelter Kooperation in der Versorgung von Patienten mit entzündlichem Rheuma/StärkeR (Förderkennzeichen: 01NVF17004)Google Scholar
  5. 5.
  6. 6.
    Krause D, Gabriel B, Herborn G, Braun J, Rau R (2014) The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline. Clin Exp Rheumatol 32(3):395–400PubMedGoogle Scholar
  7. 7.
    Krause D, Gabriel B, Herborn G, Braun J, Rau R (2015) Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 33(5):611–616PubMedGoogle Scholar
  8. 8.
    Krause D, Gabriel B, Herborn G, Braun J, Rau R (2016) Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis. Clin Rheumatol 35(5):1123–1127CrossRefPubMedGoogle Scholar
  9. 9.
    Krause C, Herborn G, Braun J, Rudolf H, Wassenberg S, Rau R, Krause D (2017) Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline. Clin Exp Rheumatol 35(3):384–389PubMedGoogle Scholar
  10. 10.
    Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, Krause D, Schmitz-Bortz E, Flörecke M, Bollow M, Braun J (2012) The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study. Ann Rheum Dis 71(7):1207–1211CrossRefPubMedGoogle Scholar
  11. 11.
    Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, Krause D, Schmitz-Bortz E, Flörecke M, Bollow M, Braun J (2012) Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res (hoboken) 64(9):1415–1422CrossRefGoogle Scholar
  12. 12.
    Baraliakos X, Kiltz U, Peters S, Appel H, Dybowski F, Igelmann M, Kalthoff L, Krause D, Menne HJ, Saracbasi-Zender E, Schmitz-Bortz E, Vigneswaran M, Braun J (2017) Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis. Rheumatology (Oxford) 56(1):95–102CrossRefGoogle Scholar
  13. 13.
    Baraliakos X, Regel A, Kiltz U, Menne HJ, Dybowski F, Igelmann M, Kalthoff L, Krause D, Saracbasi-Zender E, Schmitz-Bortz E, Braun J (2017) Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford).  https://doi.org/10.1093/rheumatology/kex318 Google Scholar
  14. 14.
    Baraliakos X, Heldmann F, Callhoff J, Suppiah R, McQueen FM, Krause D, Klink C, Schmitz-Bortz E, Igelmann M, Kalthoff L, Kiltz U, Schmuedderich A, Braun J (2016) Quantification of bone marrow edema by magnetic resonance imaging only marginally reflects clinical neck pain evaluation in rheumatoid arthritis and Ankylosing Spondylitis. J Rheumatol 43(12):2131–2135CrossRefPubMedGoogle Scholar
  15. 15.
    Baraliakos X, Kiltz U, Appel H, Dybowski F, Igelmann M, Kalthoff L, Klink C, Krause D, Saracbasi E, Schmitz-Bortz E, Rahmeh F, Braun J (2017) Chronic but not inflammatory changes at the Achilles’ tendon differentiate patients with peripheral spondyloarthritis from other diagnoses—results from a prospective clinical trial. RMD Open 3(2):e541CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kiltz U, von Zabern C, Baraliakos X, Heldmann F, Mintrop B, Sarholz M, Krause D, Dybowski F, Kalthoff L, Braun J (2017) Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis—the TryCort study. Arthritis Res Ther 19(1):73CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • J. Braun
    • 1
  • X. Baraliakos
  • U. Kiltz
  • E. Schmitz-Bortz
  • L. Kalthoff
  • D. Krause
  1. 1.Rheumazentrum RuhrgebietHerneDeutschland

Personalised recommendations